Seres Therapeutics Inc (NASDAQ:MCRB)

3.38
Delayed Data
As of 4:01pm ET
 -0.02 / -0.59%
Today’s Change
2.50
Today|||52-Week Range
25.06
-59.42%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Seres Therapeutics Inc have a median target of 13.00, with a high estimate of 25.00 and a low estimate of 4.00. The median estimate represents a +284.62% increase from the last price of 3.38.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Seres Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.60
Sales
$4.5M
Reporting Date
Aug 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 2.25%
 
 
 
 
 
 
Growthannually -223.78%
 
 
 
 
 
 

Sales

Growthquarterly 204.28%
 
 
 
 
 
 
Growthannually -87.38%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.